How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,859 results for

E/M Examination Criteria

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact

with incomplete texts or secondary studies (such as editorials, editors’ letters, Master or Doctoral theses, book chapters, and articles whose complete text was unavailable). Reference lists of the selected articles were also examined to find potentially relevant documents. The criteria for including the articles were: (1) must be data analysis about zoonosis, and (2) must encompass in its study some relation between an infectious disease and wild animals in the transmission cycle of the etiological agent (...) districts, Tanzania. Onderstepoort J Vet Res 2012; 79 (2): 3137. LeBreton M, Switzer WM, Djoko CF, Gillis A, Jia H, Sturgeon MM, et al. A gorilla reservoir for human T-lymphotropic virus type 4. Nature 2014; 3 (1):10-38. Kock R. Drivers of disease emergence and spread: is wildlife to blame? Onderstepoort J Vet Res 2014; 81 (2): 1-4. Daszak P, Cunningham AA, Hyatt, AD. Anthropogenic environmental change and the emergence of infectious diseases in wildlife. Acta Trop 2001; 78 (2):103-116. Martinez E

2020 Covid-19 Ad hoc papers

182. Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis Full Text available with Trip Pro

, Chughtai AA , et al. Cluster randomised controlled trial to examine medical mask use as source control for people with respiratory illness . BMJ Open . 2016 ; 6 ( 12 ):e012330. 15 Moher D , Liberati A , Tetzlaff J , Altman DG . Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement . BMJ . 2009 ; 339 :b2535. 16 Higgins JP , Green S . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]; 2011 . 17 Patsopoulos NA , Evangelou E (...) in cough aerosols generated in a simulated patient examination room . Clin Infect Dis . 2012 ; 54 ( 11 ): 1569 ‐ 1577 . 25 Balazy A , Toivola M , Adhikari A , Sivasubramani SK , Reponen T , Grinshpun SA . Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks . Am J Infect Control . 2006 ; 34 ( 2 ): 51 ‐ 57 . 26 Cowling BJ , Fung RO , Cheng CK , et al. Preliminary findings of a randomized trial of non‐pharmaceutical interventions to prevent

2020 Covid-19 Ad hoc papers

183. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

fever, fatigue,dry cough,dyspnea etc.,withorwithout nasalcon- gestion, runny nose or other upper respiratory symptoms [13, 16]. Despite the atypical symptoms were reported [25], Nan-Shan Zhong, the academician of Chinese Acad- emy of Engineering in an exclusive interview with Xinhua News Agency on 28 January 2020, pointed out that fever is stillthe typicalsymptomof 2019-nCoV infection. 5.2 Physical examination Patients with mild symptoms may not present positive signs. Patients in severe condition (...) may have shortness of breath, moist rales in lungs, weakened breath sounds, dullness in percussion, and increased or decreased tactile speech tremor, etc. 5.3 Imaging examination 5.3.1 CT imaging (strong recommendation) The imaging findings vary with the patient’s age, immun- ity status, disease stage at the time of scanning, underlying diseases, and druginterventions. Table 3 Recommendations for those with close contacts and suspicious exposures No. Recommendation items Recommendation strength 1

2020 Covid-19 Ad hoc guidelines

184. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

, Michelle Ng Gong 6 , Eddy Fan 7 , Simon Oczkowski 1,2 , Mitchell M. Levy 8,9 , Lennie Derde 10,11 , Amy Dzierba 12 , Bin Du 13 , Michael Aboodi 6 , Hannah Wunsch 14,15 , Maurizio Cecconi 16,17 , Younsuck Koh 18 , Daniel S. Chertow 19 , Kathryn Maitland 20 , Fayez Alshamsi 21 , Emilie Belley-Cote 1,22 , Massimiliano Greco 16,17 , Matthew Laundy 23 , Jill S. Morgan 24 , Jozef Kesecioglu 10 , Allison McGeer 25 , Leonard Mermel 8 , Manoj J. Mammen 26 , Paul E. Alexander 2,27 , Amy Arrington 28 , John (...) Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) Intensive Care Medicine GUIDELINES Un-edited accepted proof* © European Society of Intensive Care Medicine and the Society of Critical Care Medicine 2020 1 Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) Authors Waleed Alhazzani 1,2 , Morten Hylander Møller 3,4 , Yaseen M. Arabi 5 , Mark Loeb 1,2

2020 Covid-19 Ad hoc guidelines

185. Covid-19: National supporting guidance for Scottish General Practice

General Practitioner’s Committee and the Royal College of General Practitioners. This guidance should be viewed alongside the joint Scottish Government, BMA and RCGP letter to GP practices issued on 13 March, as well as the Circular to Health Boards issued by the Scottish Government on 5 March (PCA(M)(2020)02). This is intended to represent the most up-to-date and comprehensive set of guidance available to date. We appreciate that you are incredibly busy, but we ask that everyone working in General (...) Government. These are available on the SHOW website. At the time of writing, relevant publications are as follows: a. PCA(M)2020(02) – Covid-19: Guidance on Planning and Responding to Primary Care GP Practice Capacity Challenges b. PCA(M)2020(03) – NHS Near Me c. PCA(M)20202(04)- Suspension of Online Booking systems d. GP Support Letter – 13/3/2020 ? Other organisations such as RCGP Scotland also have very helpful information. For example RCGP Scotland have published actions cards for use by different

2020 Covid-19 Ad hoc guidelines

186. What is the effectiveness and safety of antiviral or antibody treatments for coronavirus?

. The Journal of hospital infection. 2019;101(1):42-46. Zhao Z, Zhang F, Xu M, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. Journal of medical microbiology. 2003;52(Pt 8):715-720. Alkhadhairi E; Alzubairy S; Abuzaid MA, A. Ribavirin plus interferon in the management of Middle East respiratory syndrome coronavirus: a historical control study of 113 patients [Corrigendum to 2017 ACCP Annual Meeting]. Pharmacotherapy. 2018;38 (...) What is the effectiveness and safety of antiviral or antibody treatments for coronavirus? What is the effectiveness and safety of antiviral or antibody treatments for coronavirus? - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website What is the effectiveness and safety of antiviral or antibody treatments for coronavirus? March 26, 2020 Patricia Rios, Amruta Radhakrishnan, Jesmin Antony, Sonia M. Thomas

2020 Oxford COVID-19 Evidence Service

187. Guidance for maternal medicine in the evolving coronavirus (COVID-19) pandemic

considerations for the car e of pr egnant women with pre-existing co-morbidities during the COVID-19 pandemic The UK Government has identified a list of medical co-morbidities, individuals with which are considered vulnerable to severe COVID-19 disease. 1 Adults with these co-morbidities are advised to be particularly stringent with social distancing measures. Adults with some co-morbidities have been identified as ‘extremely vulnerable’ to the severe effects of COVID-19 and should be ‘shielded’. 2 (...) that render adults more vulnerable to the consequences of infection. In making these recommendations, we have attempted to balance the risk of unrecognised maternal and fetal complications due to pre-existing co-morbidities against the potential risks of COVID-19. We have also considered the potential resource constraints faced by hospitals during this pandemic.6 3.1 Hypertension Authors: Shakila Thangaratinam, Lucy Chappell 3.1.1 Chronic hypertension Send blood for urea & electrolytes (U&E) and urine

2020 Royal College of Obstetricians and Gynaecologists

188. Covid-19: Infrared Temperature Screening to Identify Potentially Infected Staff or Visitors Presenting to Healthcare Facilities during Infectious Disease Outbreaks

limitations and strengths: The evidence base is fairly large and up to date. The effectiveness of airport screening with IR devices has been examined in a recent SR with 27 studies, and the effectiveness of IR device screening has been examined in an SR with 20 studies and 11 additional studies identified in our searches. Most of the studies were conducted outside the United States, but two of the newest diagnostic cohort studies were conducted in the United States. Variations across studies are due (...) primarily to variations in the devices used both for noncontact IR measurements and standard reference temperature measurements. CLINICAL EVIDENCE ASSESSMENT Infrared Temperature Screening to Identify Potentially Infected Staff or Visitors Presenting to Healthcare Facilities during Infectious Disease Outbreaks © March 2020 ECRI | ii Executive Summary Conclusions We assessed studies that examined use at airports and healthcare facilities. - 1 SR (Mouchtouri et al. 2019) examined exit and entry screening

2020 Covid-19 Ad hoc papers

189. Covid-19: Safety of Extended Use and Reuse of N95 Respirators

the safety of N95 reuse and extended use during critical shortages, so we examined 21 laboratory studies because they may provide at least some rational basis for actions during a crisis. Also, clinical studies are likely unavailable and infeasible because of major ethical and logistical barriers since N95 reuse/extended use practices are associated with sporadic, unpredictable, variable crisis situations. Nonetheless, limited evidence from laboratory studies supports prioritizing extended use over reuse (...) a method to assess model-specific parameters for ultraviolet-C (UV- C, 254 nm) decontamination of FFRs.” “Circular coupons, excised from the FFRs [3M 1860, 1870 and 8210; Kimberly- Clark PFR95-174; and two non-medical N95s] were exposed to aerosolized particles containing MS2 coliphage and treated with IFM-specific UV-C doses ranging from 38 to 4707 J m(-2).” “Models exposed to a minimum IFM dose of 1000 J m(-2) demonstrated at least a 3 log reduction (LR) in viable MS2. Model-specific exposure times

2020 Covid-19 Ad hoc papers

190. Regional Therapies for Colorectal Cancer Liver Metastases

Regional Therapies for Colorectal Cancer Liver Metastases Guideline 2-30a A Quality Initiative of the Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario) Regional Therapies for Colorectal Cancer Liver Metastases P. Karanicolas, R. Beecroft, R. Cosby, E. David, M. Kalyvas, E. Kennedy, G. Sapisochin, R. Wong, K. Zbuk and the Gastrointestinal Disease Site Group Report Date: March 10, 2020 For information about this document, please contact Dr. Paul Karanicolas or Dr. Robert (...) Beecroft, the lead authors, through the PEBC via: Phone: 905-527-4322 ext. 42822 Fax: 905 526-6775 E-mail: ccopgi@mcmaster.ca For information about the PEBC and the most current version of all reports, please visit the OH (CCO) website at http://www.cancercare.on.ca/ or contact the PEBC office at: Phone: 905-527-4322 ext. 42822 Fax: 905 526-6775 E-mail: ccopgi@mcmaster.ca PEBC Report Citation (Vancouver Style): Karanicolas P, Beecroft R, Cosby R, David E, Kalyvas M, Kennedy E, Sapisochin G, Wong R

2020 Cancer Care Ontario

191. Minimal Residual Disease Testing in Acute Leukemia

Feilotter, the lead authors, through the PEBC via: Phone: 905-527-4322 ext. 42822 Fax: 905 526-6775 E-mail: ccopgi@mcmaster.ca For information about the PEBC and the most current version of all reports, please visit the Ontario Health (CCO) website at http: https://www.cancercareontario.ca/en/guidelines- advice or contact the PEBC office at: Phone: 905-527-4322 ext. 42822 Fax: 905 526-6775 E-mail: ccopgi@mcmaster.ca PEBC Report Citation (Vancouver Style): Sabloff M, Feilotter H, Sivajohanathan D (...) Minimal Residual Disease Testing in Acute Leukemia Guideline MOTAC-6 A Quality Initiative of the Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario) Minimal Residual Disease Testing in Acute Leukemia M. Sabloff, H. Feilotter, D. Sivajohanathan, C. Howlett, C. Ross, A. Schuh, A. Pollett and the Minimal Residual Disease Testing Guideline Development Group Report Date: March 10, 2020 For information about this document, please contact Dr. Mitchell Sabloff or Dr. Harriet

2020 Cancer Care Ontario

192. Rational use of personal protective equipment for coronavirus disease (COVID-19)

possible, to establish differentiated care pathways that minimize mixing of known or suspected COVID-19 patients with other patients (e.g. through separate health facilities, wards, waiting, and triage areas). • Environmental and engineering controls aim at reducing the spread of pathogens and the contamination of surfaces and inanimate objects. They include providing adequate space to allow social distance of at least 1 m to be maintained between patients and health care workers and ensuring (...) spatial distance of at least 1 metre from other patients. • Have the patient perform hand hygiene Patients without respiratory symptoms Any • No PPE required • Have the patient perform hand hygiene Consultation room Health care workers Physical examination of patient with symptoms suggestive of COVID-19 • Medical mask • Gown • Gloves • Eye protection • Perform hand hygiene Health care workers Physical examination of patients without symptoms suggestive of COVID-19 • PPE according to standard

2020 WHO Coronavirus disease (COVID-19) Pandemic

193. Clinical care of severe acute respiratory infections – Tool kit

. EPIDEMIOLOGY 1 Summary 2 References and resources 3 1.1 COVID-19 fact sheet 4 1.2 Other viruses with pandemic potential 5 2. SCREENING, TRIAGE AND INITIAL APPROACH 7 Summary 8 References and resources 9 2.1 Screening and triage 11 2.2 Interagency Integrated Triage Tool 13 2.3 Basic emergency care (BEC): ABCDE approach to the acutely ill 16 2.4 Memory aid: key criteria used to assess nutrition and vital signs in children 25 2.5 Memory aid for pregnant women: key physiological aspects 26 2.6 Decision-making (...) References and resources 115 10.1 Numerical pain assessment scales 117 10.2 Behavioural pain assessment scales 118 10.3 COMFORT-B Scale to assess sedation in children 122 10.4 Richmond Agitation-Sedation Scale (RASS) 125 10.5 Flowchart and worksheet for the Confusion Assessment Method of the ICU for adults (CAM-ICU) 126 10.6 Flowchart and worksheet for the Confusion Assessment Method of the ICU for children (pCAM-ICU) 128 10.7 Procedure for assessing attention: attention screening exam (ASE) for adults

2020 WHO Coronavirus disease (COVID-19) Pandemic

194. Covid-19: Effectiveness and safety of antiviral or antibody treatments for coronavirus

Covid-19: Effectiveness and safety of antiviral or antibody treatments for coronavirus Prepared By: Knowledge Translation Program Li Ka Shing Knowledge Institute St. Michael’s Hospital Contact: Dr. Andrea Tricco E: Andrea.Tricco@unityhealth.to T: 416-864-6060 ext.77521 Effectiveness and safety of antiviral or antibody treatments for coronavirus A rapid review Prepared for Public Health Agency of Canada Submitted 2/25/2020 . CC-BY-NC-ND 4.0 International license It is made available under (...) a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 23, 2020. . https://doi.org/10.1101/2020.03.19.20039008 doi: medRxiv preprint i Contributors: Patricia Rios, Amruta Radhakrishnan, Jesmin Antony, Sonia Thomas, Matthew Muller, Sharon E. Straus, Andrea C. Tricco. Acknowledgements: Jessie McGowan (literature search), Tamara Rader (literature search), Krystle

2020 Covid-19 Ad hoc papers

195. CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic

/CIRCULATIONAHA.120.047011 6 standard protocols. For patients in whom COVID-19 has not been ruled out temporarily (in areas outside Hubei Province, without epidemiological history of COVID-19, with 1-2 clinical manifestations of COVID-19, but not fulfilling diagnostic criteria for COVID-19), medical management should comply with guidance from a COVID-19 expert panel in the hospital, as well as senior hospital administrative leadership. This includes quarantine in a single-bed room (initiating second grade (...) protection [3] ) (For details of protection grade for medical staff, please see Supplemental Figure 1), close monitoring for changes in clinical manifestations, lung CT imaging, and COVID-19 nucleic acid testing as soon as possible. The Chinese Clinical Guideline for COVID-19 Diagnosis and Treatment (5 th edition) [4] added diagnostic imaging features of pneumonia to the clinical diagnostic criteria for suspected cases in Hubei Province. Considering that some asymptomatic patients may be a source

2020 Covid-19 Ad hoc guidelines

196. Estimate of the economic costs and literature review of the benefits of dedicated research time for Hospital Consultants in the NHS

FP, Denduluri N, Kim ES. Critical aspects of a sustainable clinical research program in the community-based oncology practice. American Society of Clinical Oncology Educational Book. 39:176-184, 2019. Glover M, Montague E, Pollitt A, Guthrie S, Hanney S, Buxton M, Grant J. Estimating the Returns to United Kingdom Publicly Funded Musculoskeletal Disease Research in Terms of Net Value of Improved Health Outcomes. Health Research Policy and Systems. 16. 10.1186/s12961-017-0276-7. 2018. Grant J (...) , Buxton MJ. Economic returns to medical research funding. BMJ Open 2018;8:e022131 References Hiscock H, Ledgerwood K, Danchin M, Ekinci E, Johnson E, Wilson A. Clinical research potential in Victorian hospitals: the Victorian clinician researcher needs analysis survey. Internal Medicine Journal. 44(5): 477-82, 2014. Jonker L and Fisher SJ. The correlation between National Health Service trusts' clinical trial activity and both mortality rates and care quality commission ratings: a retrospective cross

2020 Academy of Medical Sciences

197. The Geriatricians’ Perspective on Medical Services to Residential Aged Care Facilities (RCFs) in Australia.

, Ikegami N, Ljunggren G, Carrilo E, Fries B. Rug-III and resource allocation: comparing the relationship of direct care time with patient characteristics in five countries. Age and Ageing 1997 26- S2:61-65. 9. Hawes C, Morris J, Phillips C, Fries B, Murphy K, Mor V. Development of the nursing home Resident Assessment Instrument in the USA. Age and Ageing 1997 26-S2: 19-25 10. Fries B, Scholl M, Hawes C, Gilgen, Jonsson P, Park P. Approaching cross- national comparisons of nursing home residents. Age (...) for the difficulties encountered in attracting GPs to care for residents in RCFs. [36] He commented that the 44 criteria currently in place do not impose a requirement for the provision of adequate medical care, and suggests a review of the decade old criteria. He makes a number of suggestions for improved medical care for this population, including adequate remuneration that acknowledges the high proportion of non face to face work involved, improved recruitment of registered nurses, improved IT infrastructure

2020 Australian and New Zealand Society for Geriatric Medicine

198. Factors Informing Clinical Decisions about Ventilator Use during Ventilator Shortages in an Infectious Disease Pandemic

their use (i.e., who gets one, when to terminate care). Factors that may inform decision making during ventilator shortages include patient age, presence of comorbidities, expected survival, and existence of advanced directives. In this report, we examine the effectiveness of triage systems for identifying disease severity and mortality risk to inform decisions on scarce resource allocation during pandemics. The Evidence Bar™ Evidence raises concerns We identified 14 guidelines, 4 triage frameworks (...) priorities on the framework’s criteria, including palliative care for patients with SOFA >11. Authors reported on survival rates for each triage group, number of ventilator and ICU days, and triage officers’ decision-making abilities. Scoring Systems, Guidelines, Position and Consensus Statements Searched PubMed, EMBASE, and ECRI Guidelines Trust® (EGT) for relevant documents published January 1, 2000, through April 2, 2020. We identified 24 documents. Scoring Systems: We identified 10 scoring systems

2020 Covid-19 Ad hoc papers

199. Safety of Extended Use and Reuse of N95 Respirators

of N95 reuse and extended use during critical shortages, so we examined 21 laboratory studies because they may provide at least some rational basis for actions during a crisis. Also, clinical studies are likely unavailable and infeasible because of major ethical and logistical barriers since N95 reuse/extended use practices are associated with sporadic, unpredictable, variable crisis situations. Nonetheless, some evidence from laboratory studies supports prioritizing extended use over reuse because (...) . universities, published a cautionary fact sheet on N95 decontamination methods - April 3, 2020: FDA issued an Emergency Use Authorization for non-NIOSH-approved N95 respirators made in China, which makes KN95 respirators eligible for authorization if certain criteria are met, including evidence demonstrating that the respirator meets certain standards.” CLINICAL EVIDENCE ASSESSMENT Safety of Extended Use and Reuse of N95 Respirators © April 16, 2020 ECRI | 4 - April 2, 2020: a news article announced

2020 Covid-19 Ad hoc papers

200. How will seasonal changes impact the COVID-19 pandemic?

Journal. https://doi.org/10.2139/ssrn.3550308 7. Neher, R., Dyrdak, R., Druelle, V., Hodcroft, E., & Albert, J. (2020). Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. Swiss Medical Weekly. https://doi.org/10.4414/smw.2020.20224 8. Bannister-Tyrrell, M., Meyer, A., Faverjon, C., & Cameron, A. (2020). Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th February 2020. https://doi.org/10.1101 (...) to suggest weather conditions may influence transmission, however all estimates are subject to significant biases. Methods (Appendix 1) PubMed and Google were searched on 1 April 2020. Studies were included if they referred to seasonal changes and coronaviruses and influenza together, or if they referred to seasonal changes and COVID-19. Exclusion criteria were no abstract was available, a focus on influenza without consideration of coronaviruses. Results (Tables 1 and 2) Preliminary models show some

2020 Covid-19 Ad hoc papers

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>